Select Page

New Danish health care reform can be a barrier for access to Interreg funding of life science innovation

The recently tabled proposal for a new Danish health care reform has many promising elements. However, the idea to let the municipalities take over the responsibility as regards attracting EU/Interreg funding for Danish life science innovation is bad for business and innovation, as MVA CEO Anette Steenberg highlights in her latest piece in Danish “Dagens Medicin”

Most recent news